相关实验视频

Updated: May 9, 2025

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

对抗表皮生长因子受体 (EGFR) 的基于Stx2a的新型免疫毒素的构建和评估

Negar Akhzari¹, Jafar Amani², Golnaz Tajadod³

¹Department of Cell Biology, North Tehran Branch, Islamic Azad University, Tehran, Iran.

Biologicals : journal of the International Association of Biological Standardization

|May 2, 2025

概括

我们开发了一种针对EGFR表达性癌症的新型免疫毒素. 将这种免疫毒素封装在纳米粒子中增强了其杀死癌症的能力和细胞吸收,显示出有效的癌症治疗的前景.

科学领域:

在瘤学瘤学.
生物技术是生物技术.
分子生物学分子生物学

背景情况:

免疫毒素 (IT) 是用于向癌症治疗的工程蛋白质.
皮表皮生长因子受体 (EGFR) 是许多癌症的关键标.
选用了帕尼图穆马布衍生的scFv和Shiga毒素A亚单元2 (Stx2a),因为它们具有向性和细胞毒性.

研究的目的:

设计和制造一种针对EGFR的新型免疫毒素.
评估免疫毒素及其纳米粒子配方的体外细胞毒性.
评估这种免疫毒素作为癌症治疗的潜力.

主要方法:

一种免疫毒素的计算设计,该免疫毒素将抗EGFR scFv (来自Panitumumab) 与Stx2a.
对HCT-116和HEK293细胞进行重组表达,净化和体外细胞毒性测定.
将免疫毒素封装在基托桑纳米颗粒中,以提高输送和疗效.

主要成果:

这种新型免疫毒素对表达EGFR的HCT-116癌细胞具有显著的向性细胞毒性.
在非标HEK293细胞中观察到最小的毒性,表明特异性.
基托桑纳米粒子配方增强了细胞吸收,并提高了免疫毒素的细胞毒性.

结论:

设计的免疫毒素是针对EGFR表达性癌细胞的强大和特异性剂.
纳米颗粒封装改善了免疫毒素的输送和治疗疗效.
这种方法对开发基于免疫毒素的新型癌症疗法充满希望.

关键词:

癌症癌症癌症癌症基托桑纳米颗粒基托桑纳米粒子欧洲农业基金会 (EGFR) 是一个基金.免疫毒素是一种免疫毒素.Stx2a 在线观看

更多相关视频

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

Author Spotlight: High-Throughput Screening of CAR T-Cell Constructs for Enhanced Cytotoxicity and Immunologic Memory

Author Spotlight: High-Throughput Screening of CAR T-Cell Constructs for Enhanced Cytotoxicity and Immunologic Memory

Published on: October 27, 2023

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...